FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4295177798> ?p ?o ?g. }

• W4295177798 endingPage "20" @default.
• W4295177798 startingPage "17" @default.
• W4295177798 abstract "Today the problem of treatment of patients with benign prostatic hyperplasia (BPH) is the actual one. BPH is an age-related chronic progressive disease. It is especially relevant for men over the age of 50 years. According to WHO demographic data, the world’s population is becoming older, so the incidence of BPH is going to increase, that leads to a significant decline in quality of life due to dysfunction of the lower urinary tract and the presence of lower urinary tract symptoms (LUTS). The management of BPH has evolved from surgery to conservative therapy. The use of 5α- reductase inhibitors, which affects the pathogenetic links of the disease, reduces the concentration of dihydrotestosterone and induces the apoptosis of epithelial cells of the prostate, is pathogenetically justified in the treatment of BPH. The objective: to study the effectiveness of treatment of BPH with dutasteride, which belongs to the group of 5α-reductase inhibitors. Materials and methods. 58 patients with BPH 52-75 years old were examined. The persons were divided into two groups. The patients in the first group received dutasteride for 6 months, the second group – for 12 months. All patients were examined ambulatory by the laboratory and instrumental diagnostic methods: an assessment of complaints by the International Prostate Symptom Score (IPSS), an assessment of the quality of life by the QoL scale, digital rectal and ultrasound examinations, bladder ultrasound examination, uroflowmetry, prostate-specific antigen level, general blood and urinary tests, determination of creatinine and urea. Uroflowmetry assessed the rate of urodynamics, identified and determined the degree of urinary disorders . Results. A positive effect of dutasteride treatment was observed in patients of both groups, but the best results were in the second group. The regression of LUTS, decreased pancreatic volume and residual urine output were in the patients. Conclusions. The results of the research demonstrated that dutasteride is an effective agent in the treatment of benign prostatic hyperplasia (BPH), which acts on the mechanism of hyperplasia. The drug is well tolerated by patients. The effect of dutasteride treatment is achieved through its continuous and long-term use. The timely diagnosis of BPH and its treatment will allow to stop the pathological process and return the man to a normal quality of life." @default.
• W4295177798 created "2022-09-11" @default.
• W4295177798 creator A5012460644 @default.
• W4295177798 date "2022-06-30" @default.
• W4295177798 modified "2023-09-30" @default.
• W4295177798 title "Dustarin in the Treatment of Patients with Benign Prostatic Hyperplasia" @default.
• W4295177798 cites W1866344063 @default.
• W4295177798 cites W1986878226 @default.
• W4295177798 cites W2006466220 @default.
• W4295177798 cites W2100819296 @default.
• W4295177798 cites W2141838252 @default.
• W4295177798 cites W2148655516 @default.
• W4295177798 cites W2168243897 @default.
• W4295177798 cites W2552252437 @default.
• W4295177798 cites W2622257203 @default.
• W4295177798 cites W2766742479 @default.
• W4295177798 cites W2770361119 @default.
• W4295177798 cites W2802739768 @default.
• W4295177798 cites W2908227836 @default.
• W4295177798 doi "https://doi.org/10.30841/2307-5090.1-2.2022.263898" @default.
• W4295177798 hasPublicationYear "2022" @default.
• W4295177798 type Work @default.
• W4295177798 citedByCount "0" @default.
• W4295177798 crossrefType "journal-article" @default.
• W4295177798 hasAuthorship W4295177798A5012460644 @default.
• W4295177798 hasBestOaLocation W42951777981 @default.
• W4295177798 hasConcept C121608353 @default.
• W4295177798 hasConcept C126322002 @default.
• W4295177798 hasConcept C126894567 @default.
• W4295177798 hasConcept C159110408 @default.
• W4295177798 hasConcept C2775874879 @default.
• W4295177798 hasConcept C2776235491 @default.
• W4295177798 hasConcept C2776547966 @default.
• W4295177798 hasConcept C2777333188 @default.
• W4295177798 hasConcept C2777562237 @default.
• W4295177798 hasConcept C2777911890 @default.
• W4295177798 hasConcept C2778878792 @default.
• W4295177798 hasConcept C2779478474 @default.
• W4295177798 hasConcept C2779881493 @default.
• W4295177798 hasConcept C2779951463 @default.
• W4295177798 hasConcept C2780101318 @default.
• W4295177798 hasConcept C2908647359 @default.
• W4295177798 hasConcept C29456083 @default.
• W4295177798 hasConcept C71315377 @default.
• W4295177798 hasConcept C71924100 @default.
• W4295177798 hasConcept C77411442 @default.
• W4295177798 hasConcept C99454951 @default.
• W4295177798 hasConceptScore W4295177798C121608353 @default.
• W4295177798 hasConceptScore W4295177798C126322002 @default.
• W4295177798 hasConceptScore W4295177798C126894567 @default.
• W4295177798 hasConceptScore W4295177798C159110408 @default.
• W4295177798 hasConceptScore W4295177798C2775874879 @default.
• W4295177798 hasConceptScore W4295177798C2776235491 @default.
• W4295177798 hasConceptScore W4295177798C2776547966 @default.
• W4295177798 hasConceptScore W4295177798C2777333188 @default.
• W4295177798 hasConceptScore W4295177798C2777562237 @default.
• W4295177798 hasConceptScore W4295177798C2777911890 @default.
• W4295177798 hasConceptScore W4295177798C2778878792 @default.
• W4295177798 hasConceptScore W4295177798C2779478474 @default.
• W4295177798 hasConceptScore W4295177798C2779881493 @default.
• W4295177798 hasConceptScore W4295177798C2779951463 @default.
• W4295177798 hasConceptScore W4295177798C2780101318 @default.
• W4295177798 hasConceptScore W4295177798C2908647359 @default.
• W4295177798 hasConceptScore W4295177798C29456083 @default.
• W4295177798 hasConceptScore W4295177798C71315377 @default.
• W4295177798 hasConceptScore W4295177798C71924100 @default.
• W4295177798 hasConceptScore W4295177798C77411442 @default.
• W4295177798 hasConceptScore W4295177798C99454951 @default.
• W4295177798 hasIssue "1-2" @default.
• W4295177798 hasLocation W42951777981 @default.
• W4295177798 hasLocation W42951777982 @default.
• W4295177798 hasOpenAccess W4295177798 @default.
• W4295177798 hasPrimaryLocation W42951777981 @default.
• W4295177798 hasRelatedWork W1964928662 @default.
• W4295177798 hasRelatedWork W2027448886 @default.
• W4295177798 hasRelatedWork W2035004660 @default.
• W4295177798 hasRelatedWork W2041830186 @default.
• W4295177798 hasRelatedWork W2043149843 @default.
• W4295177798 hasRelatedWork W2085062461 @default.
• W4295177798 hasRelatedWork W2768915954 @default.
• W4295177798 hasRelatedWork W3174598318 @default.
• W4295177798 hasRelatedWork W3175503089 @default.
• W4295177798 hasRelatedWork W1556591654 @default.
• W4295177798 isParatext "false" @default.
• W4295177798 isRetracted "false" @default.
• W4295177798 workType "article" @default.